FDA Inspection 1228657 — Mithra Pharmaceuticals Cdmo SA
The FDA completed an inspection of Mithra Pharmaceuticals Cdmo SA on Dec 2, 2022 in Flemalle. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI)
- End Date
- Dec 2, 2022
- Fiscal Year
- 2023
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Flemalle (Belgium)
Additional Details
Mutual Recognition Agreement (MRA)